1. Phase 1 results of PTC596, a novel small molecule targeting cancer stem cells (CSCs) by reducing levels of BMI1 protein. (December 2016) Authors: Shapiro, G.; Bedard, P.; Infante, J.; Bauer, T.; Prawira, A.; Laksin, O.; Weetall, M.; Baird, J.; Branstrom, A.; O'Mara, E.; Spiegel, R. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗